Fresenius Kabi Oncology: Updates on Delisting Offer

DSP Merrill Lynch Ltd ('Manager to the Delisting Offer') on behalf of Fresenius Kabi (Singapore) Pte Ltd (?Acquirer?) has informed this public corrigendum (?Corrigendum?) to the Public Delisting Announcement to the shareholders of Fresenius Kabi Oncology Ltd (?Target Company?) in accordance with the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 and to the letter of offer issued in respect thereof inviting Bids from all Public Shareholders of the Company (?Letter of Offer?), is in continuation of and should be read in conjunction with
the PA and the Letter of Offer.